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INTRODUCTION OF H-2Dd DETERMINANTS INTO THE
H-2Ld ANTIGEN BY SITE-DIRECTED MUTAGENESIS
BY DAVID KOELLER,* RONALD LIEBERMAN,* JUN-ICHI MIYAZAKI,*
ETTORE APPELLA,t KEIKO OZATO,* DONALD W. MANN,§ and
JAMES FORMAN§
From the *Laboratory ofDevelopmental and Molecular Immunity, National Institute of Child
Health and Human Development; the *Laboratory of Cell Biology, National Cancer Institute,
National Institutes ofHealth, Bethesda, Maryland 20892; and the §Department of
Microbiology, University of Texas Health Science Center at Dallas, Dallas, Texas 75235
A hallmark of MHC class I antigens is their high degree of polymorphism,
which is thought to have been generated by gene conversion and subsequent
selection (1) . The MHC-restricted T cell recognition of foreign antigens depends
on the polymorphic portions of MHC antigens . A mismatch in polymorphic
MHC class I loci within a species evokes unusually high levels of alloreactive T
cells (2, 3) and complex antibody responses (4), Though there are a number of
hypotheses, the basis of this vigorous alloresponsiveness within a species has not
been fully elucidated (5).
In recent years, efforts have been made to define the sites within an MHC
class I antigen that are responsible for eliciting alloreactivity and H-2 restriction .
Studies of in vivo-generated H-2Kb mutants (1) and recombinant MHC class I
genes engineered in vitro (6-13) have revealed that the first (a-1) and second (a-
2) external domains of the molecule, but not the third (a-3) domain, are
responsible for alloreactivity and MHC restriction . It has been shown (6-13) that
alloantibodies can recognize determinants within a single domain independent
of adjacent domains, while most CTL recognize conformational determinants
dependent on the interaction of the a-1 and a-2 domains.
Unlike other antigenic molecules in which positions ofepitopes are well defined
(14-16), the precise localization of allodeterminants of an MHC class I antigen
has only begun (1, 17, 18) . Previously, we postulated (10) that the region of
amino acids 63-73 of the a-1 domain of the H-2Dd (Dd) antigen forms alloanti-
genic sites to which mAbs specific for the Dd antigen react. This was based on a
comparison of the primary amino acid sequences of H-2 antigens and their
predicted secondary structures . The role of this region of the MHC molecule in
controlling CTL epitopes has been unexplored, largely because all ofthe in vivo-
derived H-2 mutant and HLA subtype molecules that have been characterized
biochemically do not have alterations between residues 63 and 73 (13) . To test
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whether this portion of the molecule controls antigenic sites recognized by both
mAbs and CTL, we have undertaken sequential site-directed mutagenesis of the
Ld gene to generate amino acid sequences identical to those of the Dd antigen in
the region from positions 63-73 . We show that after mutation at residues 63,
65, and 66 and again after a further mutation at residue 70, the Ld antigen gains
Dd-specific determinants recognized by both alloreactive antibodies and CTL.
Although these mutations lose some Ld epitopes detected by allo CTL, serological
Ld specificities are retained . Furthermore, the mutation in these positions results
in an almost complete loss of reactivity to Ld-restricted anti-vesicular stomatitis
virus (VSV)' CTL.
Materials and Methods
Generation of Mutant Ld Genes. The mutant Ld antigens (Table I) were created by
sequential site-directed mutagenesis of the wild-type Ld gene . In four separate cycles of
mutagenesis the codons at positions 63, 65 and 66, 70, and finally 73 were changed to
those ofthe Dd amino acids . The procedure was essentially the same as previously described
(9, 19-21) . The four mutagenic oligodeoxyribonucleotides (Table 1) were synthesized on
a Vega Coder 300 (Vega Biotechnologies, Tucson, AZ) by the phosphoramidite method
(22) and purified by HPLC. Each oligomer directed one to three nucleotide substitutions,
resulting in one or two amino acid changes (Table 1) . A 1 .9-kb Xba I fragment of the Ld
gene (containing the first three exons) subcloned into an M13 vector was used as a
template for mutagenesis . After annealing the mutagenic oligomer to the template,
dsDNA was generated by primer extension with the Klenow fragment of DNA polymerase
I and DNA ligase . Phage preparations obtained after transformation of Escherichia coli
,JM 109 were then spotted onto nitrocellulose and screened by differential hybridization
at increasing temperatures with "P-end-labeled mutagenic oligomer. The template used
for each successive cycle of mutagenesis was that generated in the previous step . After
reinserting the mutated Xba I fragment back into the remaining portion of the wild-type
Ld gene, restriction analysis and dideoxy sequencing (23) were performed for final
verification of mutagenesis .
Expression ofMutant Genes in Mouse L Cells . The three mutant Ld genes and the wild-
type Ld and Dd genes were introduced into thymidine kinase-deficient mouse L cells by
the calcium phosphate coprecipitation method, using the herpes simplex thymidine kinase
gene as a selectable marker (20, 21) . Transformed cells were screened with specific anti-
Ld mAb 28-14-8 (24) . Clones expressing high levels of the mutant genes were propagated
for further characterization . Cells expressing the wild-type Ld (20, 21), Dd (12, 25), andQ10'/L' gene (26, 27) have been described.
mAbs and Cytofuorography. The Ld - and Dd-specific mAbs have been previously char-
acterized for their strain distribution (10, 28, 29) as well as domain specificity by using
Ld/Dd (30-32), Dd/DP (12), and Dd/Kd (33) recombinants (see Tables II and III) . Cyto-
fluorography was carried out as previously described (10) .
Generation and Assay of Alloreactive CTL . CTL clones have been generated from
limiting dilution cultures as previously described (34) . Anti-Q1 0d CTL clones were
generated by priming (C3H X B6 .K1)F, mice intraperitoneally with 10' L cells transfected
with the Q10d/Ld gene followed by in vitro stimulation using the same transfected L cells
as stimulators . After 8 d of culture, the cells were placed in limiting dilution to derive
clones . CTL clones were tested against L cell targets in a 4-h "Cr-release assay at a 25 :1
and 5 :1 E/T ratio . Only data for the 25:1 ratio are shown.
Generation and Assay of VSV-specific CTL . (C57BL/6 X DBA/2)F, (BDF1) mice were
inoculated with 4 X 10 7 PFU of VSV,  d . 6-7 d later, 5 X 106 of their spleen cells were
added to individual wells of 24-well plates together with 5 X 106 spleen cells treated with
'Abbreviations used in this paper : c, CTL-defined ; s, serologically defined ; VSV, vesicular stoma-
titis virus .
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anti-Thy-1 + complement that had been cultured with 10 ug/ml of LPS for 2-3 d before
infection with a temperature-sensitive mutant of VSV (tsG4 ,) at 4 PFU/cell . After 5 d the
CTL were tested against infected and uninfected L cell targets, as described (35) .
Results
Evaluation of Potential Alloantigenic Sites and Site-directed Mutagenesis.
	
We
have previously postulated that the region from amino acids 63 to 73 in the a-1
domain of the Dd antigen is involved in the generation of alloantigenic sites (10),
based on the following lines of evidence : (a) A comparison of the amino acid
sequences of murine and human MHC class I antigens shows that the region of
greatest diversity is in the a-1 domain between amino acids 63 and 83 ; (b)
according to the algorithm of Hopp and Woods (36) this region of the a-1
domain of Dd has the greatest predicted hydrophilicity . It has been shown (36)
that the antigenic portions of proteins tend to be hydrophilic; and (c) some anti-
Dd mAbs have patterns of crossreactivity to different H-2 antigens that correlate
with amino acid substitutions in this region (10) .
To evaluate the validity of this assessment we have used site-directed mutagen-
esis to sequentially replace amino acids 63, 65, 66, 70, and 73 in the a-1 domain
of the Ld antigen with those of the Dd antigen (Table 1) . The amino acid
sequences of the Ld and Dd antigen in this region, oligomers used for mutagenesis,
as well as the DNA sequences of the Dd , Ld , and the resultant mutant genes are
shown in Table I. The first mutant bears D'-type amino acids at positions 63,
65, and 66 and is designated M66 (Table IA) . Using mutant gene M66 as a
template, oligomer LE2-4 was used to change glutamine to asparagine at position
70, creating gene M70 . The final mutant, M73, was made by changing the codon
at position 73 from that of tryptophan to serine using oligomer LE2-7 . Each
mutant DNA was sequenced (23) to confirm the expected nucleotide substitution
(data not shown) .
The hydrophilicity predictions for the native Dd , Ld , and the mutant antigens
derived according to Hopp and Woods (36) are shown in Fig. 1 . The region
from positions 63 to 73 in the native Ld antigen is relatively neutral in its
predicted hydrophilicity, while this region comprises the highest predicted local
hydrophilicity in the Dd antigen (Fig . 1 a) . The three amino acid changes in
antigen M66 result in a significant increase in its predicted hydrophilicity, while
the subsequent mutation at position 70 has no effect (b and c) . The final
substitution at position 73 makes the mutant antigen almost identical to Dd in
terms of predicted hydrophilicity (c) .
Acquisition ofDd Serologically Defined (s) Epitopes by Mutations of the Ld Gene at
Positions 63-73. We introduced the mutant genes into mouse L cells and
expression of the introduced genes was monitored by binding of mAb 28-14-8.
This mAb (28) reacts with the a-3 domain of the Ld antigen and its binding is
therefore unlikely to be affected by mutations in the a-1 domain (30) . L cells
expressing the mutant antigens were tested with a panel of 41 anti-Dd mAb by
cytofluorography . These mAbs do not react with Ld (10, 30). As seen in Table
11, 12 of these antibodies react with determinants in the a-1 domain and seven
are specific for the a-2 domain of the Dd antigen . The remaining 22 mAbs react
with conformational determinants dependent on the interaction of the a-1 and
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Predicted hydrophilicity in-
dices of the mutant Ld antigens. The
predictive procedure for locating hydro-
philic portions of a protein developed by
Hopp and Woods (36) was used for the
native Ld (a), mutant M66, M70 (b), and
M73 (c) in comparison with the native
Dd antigen . Circled amino acid positions
represent the site of substitution .
a-2 domains of the Dd antigen (12) . Although the conformational nature of these
determinants were demonstrated with Dd/DP (12) and Kd/Dd recombinants (33),
it was not revealed by Dd/Ld hybrid antigens (10), presumably due to greater
homology of the Dd and Ld molecule .
As shown in Table 11, replacement of the Ld residues at positions 63, 65, and
66 with Dd residues resulted in the binding of 11 anti-Dd-specific mAbs . Four of
these mAbs are a-1 domain specific ; the remainder recognize conformational
KOELLER ET AL .
TABLE II
Binding ofDd-specific mAb to Mutant Ld Antigens
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* Cytofluorography was performed as described in Materials and Methods. Mean fluorescence values
were determined on a linear scale and normalized by subtraction of background fluorescence
obtained by negative control mAb, anti-IA' (10, 12). Binding values >22 were scored positive .
Values in parenthesis represent antibody binding scored negative . Asterisks with numbers represent
mAb with the same specificity .
Antibody Domainspecificity References
Antibody
M66
binding to
M70
transformed
M73
cells*
Dd
T.O.107 a-1 10, 12 (0) (0) (0) 676
T.O.111 (3) (0) (0) 298
T.0.119 (0) (0) (0) 332
T.0.120 (8) (0) (0) 157
T.0.124 132 317 313 326
T.0.129 (19) (13) (1) 700
T.0.131*1 (16) (1) (1) 710
T.0.133*1 (15) (3) (0) 637
T.0.136*2 376 313 527 326
T.0.137 (6) 307 205 509
34-4-21 *2 24, 30, 31 257 384 389 214
34-1-2 34 577 136 457
34-5-8 a-2 10, 12, 24, 31 (0) (12) (0) 567
T.O . 112 10, 12, 32 (0) (0) (0) 610
T.0A 13*3 (0) (0) (0) 710
T.0.114*3 (0) (0) (0) 712
T.0.117 (0) (0) (0) 533
T.0.121 (0) (8) (1) 624
T.0.123 (0) (7) (0) 580
23-5-21 a-1/a-2 28,30 (3) 23 (4) 96
T.0.104 10, 12 (0) (0) (1) 125
T.0.108*4 (11) 274 138 376
T.0 .109*4 (8) 267 68 306
T.O .110 65 395 125 329
T.O .115 (6) (0) (3) 94
T.0.116 (12) (2) (0) 149
T.0.118 (10) 257 179 392
T.0 .122 (0) 44 (0) 289
T.0.125 10 (0) (2) (0) 43
T.0.126 10, 12 (5) 156 20 314
T.0.127 431 627 464 302
T.0.128 35 569 431 184
T.0.130 10 (15) (4) (0) 255
T.0.132 10, 12 49 439 341 386
T.0.134*5 113 431 277 421
T.0.138*6 (20) (3) (0) 195
T.0.139*6 (15) (6) (0) 185
T.0.141 (5) (11) (2) 160
T.0.142*6 (5) (8) (7) 89
T.0.144*5 413 601 414 316
T.0.145 258 440 (14) 181
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determinants influenced by both the a-1 and a-2 domains (10, 12, 31, 32) . As
judged by the crossreactivity of these mAbs toward different mouse strains (10,
24, 28, 29), as well as Dd/DP(12) and Dd/Kd recombinant antigens, this represents
a minimum of nine independent specificities (34-4-21 and T.O . 136 are identical
in specificity, so are T.O .134 and T.O.144, the remaining seven mAbs show
unique reactivity) . From these results it is apparent that residues 63, 65, and 66
are involved in creating multiple Dd s-specificities, although independent contri-
butions of each amino acid to the epitope formation remain to be tested .
Afurther amino acid substitution at position 70 resulted in the gain of reactivity
of an additional seven anti-Dd mAbs . All of the mAbs reactive with M66 remained
positive for M70, making a total of 18 anti-Dd-specific mAbs that react with this
mutant antigen. Of the seven additional mAbs reacting with M70, one was a-1
domain specific (T .O.137). mAbs reactive with the a-1 domain or a-1/a-2
conformational determinants examined in this work represent 28 independent
specificities. Thus, more than half of all the s-specificities recognized by these
mAb are created at least in part by the stretch of amino acids from 63 to 70 .
The final mutation was introduced at position 73 (M73 in Table II). This
mutant antigen showed no evidence for the acquisition of new Dd determinants .
All of the a-1 domain-specific mAbs retained reactivity toward this antigen .
However, three mAbs (23-5-21, T.O . 122, and T.O . 145) that recognize confor-
mational determinants lost their reactivity . In addition, the reactivity of mAb
T.O .126 appeared to be greatly reduced (Table II). The results indicate that
residue 73 does not play an important role in formation of the a-1 domain-
specific s-epitopes for the mAbs studied here . The basis of the loss of reactivity
of the three mAbs is not clear; possibly, the conformation created by residues
63-70 of the mutant a-1 domain and the a-2 domain of the Ld antigen is altered
or destroyed by the change at position 73 . As shown in Table 11, none of the
seven a-2 domain-specific mAbs became reactive toward any of the three mutant
antigens. Consistent with these results, previous studies (12) have shown that the
determinants recognized by these antibodies are independent of the a-1 domain .
Retention of Ld-specific and LdID
d-crossreactive s-Epitopes in the Mutant Anti-
gens . Binding of mAbs specific for the Ld antigen and for shared determinants
present in both the Ld and Dd antigens is shown in Table III . All six anti-Ld
mAbs reactive with determinants in the a-1, a-2, or a-3 domains retained
reactivity to all three mutant antigens. In addition, all eight mAbs crossreactive
with the Ld and Dd antigens were positive with each of the mutants, as might
have been expected .
Ability ofAlloreactive CTL to React with Mutant Ld Molecules.
	
Bulk-cultured and
cloned anti-Ld and-Dd reactive CTL were tested against L cells expressing native
Ld, native Dd, and the mutant molecules M66, M70, and M73 . As seen in Fig. 2
(right), B10.D2(R103) (Kd, Db) anti-BALB/c-H-2d-2 (Kd, Dd (anti-Dd) CTL react
against Dd (K8-30) and M70-transfected L cells . Although weak lysis is observed
against the other two mutant Ld molecules (M66, M73), these CTL also crossreact
on the native Ld (W12). Therefore, the analysis of reactivity using CTL clones
was more informative. The four CTL clones tested showed three different
specificity patterns . Clones D.98.9 and D8.3 (not shown) recognized Dd only and
did not detect Ld or any of the mutant antigens (Fig . 3, left; Table IV, 11 A) .
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TABLE III
Binding of anti-L°, or L°/Dd Crossreaclive Antibodies to Mutant Ld Antigen
Cytofluorography was performed as described in Materials and Methods. Fluorescence values were
determined as in Table 11 .
* NT, not tested.
50 25 12
	
50 25 12
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The second pattern was displayed by clone D.88 .42, which recognized Dd and
the mutant molecules, M66 and M70, but did not react with M73 (Fig . 3, center ;
Table IV, II B) . The third pattern was displayed by clone D98.36. This clone
was derived from a CBA (Kk, Dk) anti-BALB/c-H-2dm2 culture and was found to
react not only against Dd, but Ld as well . Not unexpectedly, this clone also reacts
on all three mutant antigens (Fig . 3, right; Table IV, II C) . This pattern was also
evident in some of the anti-Q]. Od clones (see below), making it similar to the
mAbs that crossreact on both Ld and Dd.
Bulk-cultured BALB/c-H-2dm2 anti-BALB/c (Kk , Dd, Ld) (anti-H-2Ld) CTL
reacted against native Ld (W 12) and not Dd (K8-30)-transfected L cells (Fig . 2,
Antibody Specificity Reference
W12 M66
Antibody binding
M70 M73 Dd
28-14-8 Ld, a-3 28,30 499 406 494 492 NT*
66-8-2 Ld, a-3 29,32 102 119 178 199 NT
30-5-7 Ld, a-2 31 557 421 394 466 NT
23-10-1 Ld, a-2 30, 31 163 85 363 201 NT
66-3-5 Ld, a-2 29, 32 496 119 454 396 NT
64-3-7 Ld, a-1 20,21 152 325 128 134 NT
28-11-5 Ld/Dd 30,31 140 38 422 392 567
27-11-13 128 163 679 436 346
34-4-20 201 50 665 326 291
T.O . 101 10, 12 30 12 118 170 83
T.O . 102 161 30 713 307 527
T.O . 103 241 140 222 132 536
T.O . 105 234 40 764 438 424
T.O . 106 60 53 778 138 321
0
O O(W12)
A MOB
" MA
" MT!
Da1KO3D)
FIGURE 2. Lytic activity of
BALB/c-H-2dm2 anti-BALB/c
(anti-H-21, d) (left) or B10.D2
(R103) anti-BALB/c-H-2dm2
(anti-H-2Dd) CTL (right) . The
CTL were generated in 5-d
bulk culture and tested against
L cells transfected with tk, H-
2Ld (W12), M66, M70, M73,
and H-2Dd (K8-30).
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0
H
LdIW12)
M66
M70
11173
Dd(K8-30)
D.98.9 D.88 .42 D.98 .36
0 10 20 30 40 50 60 70 80
	
0 10 20 30 40 50 60 70 80 0 1020304050 60 70 80
SPECIFIC RELEASE
l%1
FIGURE 3 . Lytic activity of CTL clones generated against H-2D'. Clone D8.3 is from B10.D2
(R103) anti-BALB/c-H-2 d,2 and the other three clones are from CBA anti-BALB/c-H-2 d.2
cultures . CTL are tested against L cells transfected with tk, H-2Ld (W12), M66, M70, M73,
and H-2Dd (K8-30) . Data shown for E/T ratio of 1 :25 .
TABLE IV
Specificity Patterns ofCTL Clones
+, Strong reactivity; -, no reactivity ; ±, low lytic activity relative to that observed on Ld targets .
* Group I, patterns A-C, and group II, patterns B and C, represented by single clones. Group II,
pattern A and C, represented by two clones each . Group III, pattern A, represented by three
clones, pattern B represented by five clones.
left) . These effector cells also recognized Ld mutant molecules . M73 targets were
lysed to the least extent, whereas M70 were recognized to an extent similar to
native Ld .
This data was extended using CTL clones derived from cultures of anti-Ld
CTL (Fig . 4, Table IV). The three clones with anti-L d reactivity displayed three
different specificity patterns . Clone 1-9.4 reacts with W12, M66, M70, and M73
to an equivalent extent, indicating that the Ld epitope it recognizes is not affected
by changes in this region of the molecule . Clone L.13DAC shows an opposite
pattern of reactivity in that it recognizes Ld but does not lyse L cells expressing
any of the mutant target molecules (Table IV, I B) . Finally, clone L.13D.8A
reacts with Ld and the mutant molecule M66 with changed amino acids at 63,
65, and 66 (Table IV, I C) . Although it does not react on the M70 antigen, it
reacts weakly on M73, suggesting that the loss of the epitope introduced by the
cluster of changes at 63, 65, 66, and 70 is restored by changing residue 73 .
Group* Pattern Ld M66 M70 M73 Dd
I A + + + + -
Anti-Ld B + - - - -
C + + - + -
II A - - - - +
Anti-Dd B - + + - +
C + + + + +
III A - - + + -
Anti-Q10/L d B + ± + + ±
C + + + + +
O(W12)
MBB
WIKe-301
Ld(W12)
Dd(K9-30)
FIGURE 4 .
	
Lytic activity of CTL clones generated against H-2L'. Clone L9.4 is from (C3H
x BALB/c-H-2d-2 )F 1 anti-BALB/c and clones L.13DAC and L.13D.8A are from CBA anti-
A.AL cultures . CTL are tested against L cells transfected with tk, H-2Ld (W12), M66, M70,
M73, and H-2Dd (K8-30). Data shown for E/T ratio of 1 :25 .
Q10.110 .23
L9.4
L I I II I I I I I I I I I I 1 1 I 1 I I I I I I-L 1 1 I I
0 10 20 30 40 50 0 10 20 30 40 50 0 10 20 30 40 W
(0 .110 .54
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L.13DAC
SPECIFIC RELEASE
l%1
rno.110 .2s
FIGURE 5 . Lytic activity of CTL
clones generated against Q10d/O.I F== Anti-Q10 CTL clones were gener-
L.13DIA
ated in (C3H x B6.K1)F, mice (see
Materials and Methods) . CTL are
tested against L cells transfected with
tk, H-2Ld (W12), M66, M70, M73,
and H-2Dd (K8-30) . Although not
shown in the figure, all clones lyse
0 10 20 30 40 50 e0 70 e0 0 10 20 30 40 e0 e0 70 e0 0 10 20 30 40 50 00 70 80 QlO d/Ld-transfected L cells. Data
SPECIFIC RELEASE shown for E/T ratio of 1:25 .
1%1
We further investigated how mutation in this region of the H-2Ld molecule
would affect CTL epitopes by using CTL clones generated against Q10d. Q10d
is a class I molecule normally found in serum of most strains of mice at relatively
high concentrations (37) . Although Q10 has a mutant transmembrane domain
which accounts for its secretion (38), it can be converted into an integral
membrane protein by exon shuffling the gene with H-2Ld and transfecting the
shuffled gene into L cells (25, 26). The resultant molecule is expressed on the
membrane and bears the a-1 and a-2 domains of Q10d together with the a-3
and COOH-terminal domains derived from Ld (this molecule is referred to as
Q10d/L') . We have previously shown (27) that mice can generate a CTL response
against Q10d/Ld transfected L cells, indicating that secreted class I molecules do
not induce CTL tolerance.
Since the amino acid sequence of Q10d/Ld at position 61-75 closely resembles
that of Dd and the mutants (Table I, A), we tested anti-Q10d/Ld CTL clones
against Ld, Dd, the three Ld mutants. Three different specificity patterns were
observed . Pattern III A (Table IV) is represented by clone Q10.110.23, which
does not react against either Ld or Dd but does react against M70 and M73 (Fig .
5, left) . Pattern III B is represented by clone Q10.110 .54, which reacts against
Ld as well as Ld M70 and M73 (Fig. 5, center). These clones also display weak
75 4 MHC CLASS I EPITOPE LOCALIZATION BY IN VITRO MUTAGENESIS
U
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FIGURE 6. Lytic activity of
in vitro-cultured CTL from
(C57BL/6 x DBA/2)F,
(BDF,) mice primed with 4 x
10 7 PFU of VSV. The CTL
were generated in 5-d bulk
culture and tested against L
cells transfected with tk, H-
2Ld (W12), M66, M70, M73,
and H-2Dd (K8-30). Lysis
shown against VSV-infected
targets (400 PFU/cell) in left
panel and uninfected targets
in right panel . Spontaneous
release ranged from 11 to
32%.
reactivity against Dd and M66 . Pattern III C, represented by clone Q10.110 .26,
reacts on Ld, Dd, and all three of the mutants (Fig . 5, right) . Similar to pattern
III B clones, the acquisition of reactivity is correlated with reactivity against
M66. This last set of clones has a specificity similar to pattern 11 C clone D.98 .36,
which crossreacts on both Dd and Ld as well as all three mutants.
Taken together, the above data demonstrate that changes of amino acids in
Ld between residues 63 and 73 can affect CTL epitopes . Further, by changing
amino acid residues at only positions 63, 65, and 66 to the Dd type, the Ld
molecule acquires a Dd CTL epitope, as detected by clone D.88 .42.
Ability ofH-2Ld Mutant Molecules to Restrict Anti-VSV CTL .
	
TheCTL response
against VSV in the H-2d haplotype is restricted by Ld and not Dd (35, 39). Since
bulk-cultured alloreactive anti-Ld CTL lyse M66 and M73 targets and kill M70
cells equivalently to native Ld (Fig. 2), we wished to determine whether anti-VSV
Ld-restricted CTL would also react against the same mutant molecules . The data
in Fig. 6 show that these viral-specific CTL fail to recognize these mutant
molecules. Thus, most of the VSV-restricting epitopes on the Ld molecule appear
to be affected by changes in this region of the a-1 domain and therefore differ
from a large portion of the alloantigenic CTL epitopes, as detected in bulk
cultures .
Discussion
We have used site-directed mutagenesis to localize allodeterminants in the a-
1 domain of the Dd antigen, based on the hypothesis that the portion of the Dd
antigen formed by residues 63-73 is important for generating s-alloantigenic
epitopes . Specific mutations were introduced into the Ld gene to replace amino
acids of this region with those of the Dd type . Localization of a number of s- and
CTL-defined (c)-epitopes in the mutant antigens was made possible by the
availability of a large number of mAbs and CTL clones against the Dd or Ld
antigen representing unique specificities .
We show first that changing the three amino acids at positions 63, 65, and 66
results in a gain of nine Dd s-specificities . Secondly, we found that the additional
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amino acid substitution at residue 70 confers an unexpectedly large number of
Dd s determinants . A total of 15 Dd s-specificities were found in mutant M70,
which is more than half of the total number of s-determinants in the a-1 or a-
1/a-2 domain of the Dd molecule studied here . No additional s-epitopes were
revealed by the subsequent mutation at position 73, indicating that this position
is not crucial in creating epitopes recognized by the mAbs used . It can be
concluded that the area surrounding amino acids 63-70 serves as an "immuno-
dominant" region of the Dd molecule that produces multiple s-alloantigenic sites .
This immunodominant area appears to be involved in generating both a-1-
specific and a-1/a-2-conformational s-epitopes .
In agreement with our results, there have been several reports demonstrating
that synthetic peptides corresponding to this area of MHC class I antigens are
capable of producing antibodies that react specifically with the original antigens .
Walker et al . (40) used a peptide corresponding to residues 61-83 of HLA-B7,
and Ways et al . (41) used one derived from residues 56-69 of the HLA-A2 and
B-17 antigens . Singh et al . (42) demonstrated similar results with an octapeptide
corresponding to residues 61-69 of the H-2Kb antigen. All these investigators
were able to show specific reactivity of the antibodies to the original MHC class
I antigen in either native or denatured form . Consistent with our observations,
studies on Dd/Kd intradomain recombinants have mapped the epitopes for mAbs
T.O 124, T.O 127, T.O 136, T.O 144, and 34.2.21 into the region between
residues 57 and 65 of the Dd antigen (33) .
The pattern of reactivity of anti-Dd CTL against the Ld mutant molecules is
similar to that observed with anti-D d mAbs. Bulk-cultured anti-D' CTL demon-
strated reactivity against the Ld mutant molecule M70. Although some low level
of reactivity against M66 and M73 may have been present in these cultures, it
could not be detected, since there was weak crossreactivity observed against wild-
type Ld. Anti-Dd CTL clone (D.88.42) reacted against the Ld mutant molecules
M66 and M70. Thus, we demonstrate for the first time the generation of a CTL
epitope by transferring a specific amino acid sequence into a class I molecule .
This Dd c-epitope is similar to s-epitope(s) in that they were lost when amino acid
73 was changed from tryptophan to serine . It should be noted that this c-epitope
is likely to be dependent on the structure of the a-2 domain, since Dd c-epitopes
are readily detectable in Dd/Ld (a-1/a-2) but not in a Dd/Q7d domain-shuffled
molecule (11, 26). As expected, not all Dd c-determinants are controlled by this
region, as evidenced by the lack of reactivity of two anti-D d CTL clones against
any of the mutant Ld molecules (Table IV, 11 A) .
The importance of this region was further revealed by the reactivity of anti-
Q10d CTL clones . We previously reported (27) that anti-Q10' CTL crossreact
with H-2d antigens. The sequence of Q1 0d between residues 63 and 73 is identical
with H-2Dd (Table I) (43, 44). Some of these clones crossreact on M70 and M73
but fail to recognize Dd (Table IV, III A) . This suggests that the presence of the
Q10d 61-73 amino acid sequence in the context of Ld rather than Dd is more
permissive for the expression of the crossreactive epitope . Anti-Q10 clones that
crossreact on Dd (Table IV, 111, B and C) also acquire reactivity on M66,
suggesting that the c-epitope(s) recognized on Dd crossreacts with a determinant
on Ld, which is present only when Dd amino acids are found at residues 63, 65,
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and 66 . The introduction of additional Dd or Q10d-like sequences into the Ld
molecule (M70 and M73) further enhances the reactivity above that seen with
M66 or the wild-type Dd . Although the sequence of Q10d is identical to H-2Dd
between residues 63-73, most of the anti-Q10' CTL clones (Table IV, III, B
and C) preferentially crossreact on Ld rather than Dd . Further, the reactivity of
group 11I$clones is affected by changes in amino acids in the a-2 domain (Mann,
D. W., and J . Forman, unpublished observations) . Thus, it is likely that these
clones recognize conformational epitopes dependent on the interactions of both
a-1 and a-2 domains .
Although amino acid sequences from 63 to 70 control both s- and c-epitopes
in the Dd molecule, the same region of the Ld molecule exhibits an apparent
dichotomy in the expression of s- and c-epitopes . None of anti-L' mAbs lose
reactivity to any of the mutants tested here. That most of anti-Ld mAb to date
are a-2 and a-3 domain specific may indicate that this region (and thus the a-1
domain) of the Ld molecule does not have major serological alloepitopes . On the
other hand, reactivity of bulk-cultured anti-Ld CTL is affected by the mutations,
as evidenced by reduced reactivity against M66 and M73. More conclusively,
two of three anti-Ld CTL clones lose their reactivity to some or all mutants,
demonstrating the involvement of this region for c-allospecificity .
None of the mutant molecules were recognized by bulk-cultured, 0-restricted
anti-VSV CTL. Since we have shown that alterations in this segment can have
dramatic effects on c-epitopes, we may assume that this region makes up the
major portion of VSV-restricting epitopes . Alternatively, this part ofthe molecule
may play a role in the postulated binding of virus peptide fragments to class I
molecules (44) . The importance of the a-1 domain of Ld in controlling VSV-
restricting epitopes was previously noted by Murre et al . (31), who showed that
a Dd/Ld (a-1/a-2) hybrid molecule failed to react with restricted anti-VSV but
not antiinfluenza CTL.
What is the structural basis of the gain and loss of Dd and Ld epitopes that
were observed upon mutations at positions 63-73? As originally conceived,
increased hydrophilicity may explain s-epitope changes . High local hydrophilicity
has been proposed (36) to correlate with antigenic determinants seen by antibod-
ies . The local hydrophilicity is expected to expose the area to the surface, thus
making it more accessible to antibodies in solution . Several examples that support
this proposal have been reported (15, 36) . The replacement of the Ld amino
acids at position 63, 65, and 66 with those of the Dd type increases predicted
hydrophilicity of this region substantially, which may accord with the gain of
multiple s-epitopes . The paucity of s-determinants on this region of the Ld
antigen might be consistent with the role of hydrophilicity for s-epitope forma-
tion, as this area of Ld is low in hydrophilicity . However, the additional epitope
gain found in M70 cannot be explained by this mechanism, since no hydrophil-
icity change is expected to occur by this substitution . Furthermore, the signifi-
cance of hydrophilicity has not been implicated so far for c-epitopes . Recently,
Geysen et al . (16) proposed an alternative hypothesis for the sites of antibody
binding to an antigen . These authors examined stereochemical properties of the
myohemerythrin antigen, based on crystallographic analysis of the molecule, and
tested antibodies to the peptide homologues of the antigen . These authors found
that the most frequently recognized sites tend to have high local mobility and
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convex surface potential . Poorly recognized sites are characterized as tightly
packed, least mobile regions. No correlation was indicated between hydrophilicity
and antibody binding sites in this study. This is an attractive hypothesis, as it may
explain the role of residue 70 in creating epitopes . However, in the absence of
detailed crystallographic information (45), it is not possible to evaluate this model
for MHC class I antigens at present.
DeLisi and Berzofsky (14) have proposed a model for an antigenic structure
that is specifically recognized by T cells, distinct from that detected by antibodies .
According to this hypothesis, T cells recognize lower order structures that exhibit
amphipathic properties, as opposed to tertiary structures seen by antibodies . The
region encompassing residues 63-73 of the Dd molecule is clustered with charged
amino acids interspersed by neutral ones, which might create a structural envi-
ronment favoring an amphipathic tendency . That this region of the Ld molecule
also forms c-antigenic sites may be relevant to amphipathic properties created by
other elements, such as periodic hydrophilicity (14) .
It is possible that structural requirements for s- and c-epitopes are distinct . If
so, this region of the Dd molecule may possess structural features necessary for
creating both s- and c-epitopes .
Summary
We used site-directed mutagenesis to localize serologically defined (s) and CTL
(c)-defined alloantigenic determinants to discrete amino acid sequences of a
murine MHC class I antigen. Based on the prediction that amino acid position
63-73 of the H-2Dd antigen forms s-allodeterminants, the H-2Ld gene was
mutated in a sequential fashion to replace codons for amino acid positions 63,
65, 66, 70, and 73 with those of the H-2Dd amino acids. Epitopes of the mutant
antigens expressed in L-cells were examined by the binding of a series of mAbs
specific for the H-2Dd antigen . The mutant antigen M66 had substitutions at
residues 63, 65, and 66, and resulted in the acquisition of a number of H-2Dd-
specific s-epitopes . Mutant M70 had an additional substitution at residue 70,
which led to the gain of multiple additional H-2D' s-epitopes . Together, more
than half of all the relevant H-2D' s-epitopes were mapped into amino acid
position 63-70 of the H-2Dd molecule, which was expressed in the mutant H-
2Ld gene . The final mutation at residue 73 (M73) caused no new epitope gains,
rather, a few Dd s-epitopes acquired by the preceding mutations were lost . All of
the H-2Ld-specific s-determinants were retained in the mutant molecules, as were
H-2Dd s-determinants specific for the a-2 or a-3 domains. Changes of these
residues affected c-determinants defined by CTL. Anti-H-213d CTL cultures and
an anti-H-21)d CTL clone recognized the mutant H-2Ld molecules, M66 and
M70. Some CTL clones generated against the Q10d molecule, which has an
identical sequence to H-2Dd between residues 61 and 73, failed to recognize
native H-2Dd or Ld but did crossreact with mutant Ld. While bulk-cultured anti-
H-2Ld CTL cultures reacted strongly against M73, bulk-cultured H-2Ld re-
stricted anti-vesicular stomatitis virus CTL did not. Finally, at the clonal level
two of three anti-H-21,d CTL clones lost reactivity with some or all of these
mutant molecules. From these results we conclude that a stretch of amino acids
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from position 63 to 70 of the a-1 domain controls major s- and c-antigenic sites
on the H-2Dd antigen and c-sites on H-2Ld antigen .
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